Patents by Inventor Jonathan ENAV

Jonathan ENAV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11384077
    Abstract: Salts and solid state forms of Valbenazine, including Valbenazine ditosylate, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof are disclosed.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: July 12, 2022
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Khaled Haj Ali, Marina Yarovoy, Jonathan Enav
  • Publication number: 20220127259
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Patent number: 11242341
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: February 8, 2022
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Patent number: 10889620
    Abstract: Solid state forms of Linaclotide, processes for their preparation, compositions comprising them and medical uses thereof are provided. The solid state forms of Linaclotide are useful in the preparation of other solid state forms of Linaclotide, particularly the amorphous form.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: January 12, 2021
    Assignee: NOVETIDE LTD.
    Inventors: Chaim Eidelman, Hagi Alon, Dov Vayer, Sharon Penias-Navon, Jonathan Enav
  • Publication number: 20200347047
    Abstract: Salts and solid state forms of Valbenazine, including Valbenazine ditosylate, processes for preparation thereof, pharmaceutical compositions thereof, and uses thereof are disclosed.
    Type: Application
    Filed: November 21, 2018
    Publication date: November 5, 2020
    Inventors: Khaled Haj Ali, Marina Yarovoy, Jonathan Enav
  • Publication number: 20200048244
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Application
    Filed: October 6, 2017
    Publication date: February 13, 2020
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Publication number: 20190194256
    Abstract: Solid state forms of Linaclotide, processes for their preparation, compositions comprising them and medical uses thereof are provided. The solid state forms of Linaclotide are useful in the preparation of other solid state forms of Linaclotide, particularly the amorphous form.
    Type: Application
    Filed: July 1, 2016
    Publication date: June 27, 2019
    Inventors: Chaim EIDELMAN, Hagi ALON, Dov VAYER, Sharon PENIAS-NAVON, Jonathan ENAV
  • Publication number: 20180273499
    Abstract: The present disclosure relates to new salts of Vortioxetine, including butyrate, iso-butyrate, benzoate and propionate, solid state forms of the Vortioxetine salts, processes for the preparation thereof, pharmaceutical formulations/compositions thereof, and methods of use thereof.
    Type: Application
    Filed: March 19, 2018
    Publication date: September 27, 2018
    Applicant: Teva Pharmaceuticals International GmbH
    Inventors: Sharona SHACHANTOV, Doron RUDIK, Ariel MITTELMAN, Rotem SELLA-EREZ, Yuval COHEN, Jonathan ENAV, Vera KESELMAN, Gustavo FRENKEL, Moshe BAR, Polina LAPIDO